Five-Year FDA Debarment for Unapproved Drug Importer Alnashir Punjani
Published Date: 3/13/2025
Notice
Summary
Alnashir Alibhai Punjani is banned for 5 years from importing any drugs into the U.S. because he was convicted of a serious crime involving unapproved drugs. He didn’t ask for a hearing, so the ban starts officially on November 10, 2024. This means no drug imports from him for half a decade, protecting public health and keeping things safe.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Five-Year Drug Import Debarment
Alnashir Alibhai Punjani is banned for 5 years, beginning November 10, 2024, from importing or offering for import any drug into the United States because he was convicted of a federal felony for conspiracy to deliver and introduce unapproved drugs. He did not request a hearing within 30 days of the notice, and that failure waived his right to a hearing.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
2026-16944, Gardenia Blue Interest Group; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Gardenia Blue Interest Group (GBIG or petitioner), c/o Exponent, Inc., proposing that we amend our color additive regulations to expand the safe use of gardenia (genipin) blue in various foods at levels consistent with good manufacturing practice. The petition also proposes to lower the specification for arsenic in gardenia (genipin) blue.
Previous / Next Documents
Previous: 2025-04028, Harpreet Singh: Final Debarment Order
Harpreet Singh is banned for 10 years from importing any drugs into the U.S. because he was convicted of serious crimes like drug trafficking, fraud, money laundering, and obstructing justice. The ban starts after November 20, 2024, since he didn’t respond to the FDA’s notice or ask for a hearing. This means he can’t bring in or offer to bring in any drugs during this time.
Next: 2025-04030, Jonathan Corbett Cosie: Final Debarment Order
Jonathan Corbett Cosie is banned for 10 years from importing any drugs into the U.S. because he was convicted of selling fake or mislabeled drugs on purpose. He didn’t fight the ban, so it starts officially on January 6, 2025. This means no drug imports from him for a decade, protecting people from unsafe medicines.